Treatment of Palmar Psoriasis

First-Line Therapies

The American Academy of Dermatology recommends high-potency topical corticosteroids as the initial treatment of choice for palmar psoriasis, particularly when used under occlusion to enhance penetration 1, 2
Combination therapy with vitamin D analogues and topical corticosteroids provides enhanced efficacy and is recommended as first-line treatment by the American Academy of Dermatology 3

The American Academy of Dermatology recommends targeted phototherapy with 308-nm excimer laser as an effective treatment for localized palmar psoriasis 1, 2
Soak PUVA therapy is particularly effective for palmoplantar psoriasis, according to the British Journal of Dermatology 1, 2, 6
Topical PUVA requires treatments 2-3 times weekly for several months for adequate clearing and maintenance, as reported by the British Journal of Dermatology 6

Oral retinoids, particularly acitretin, are highly effective for palmar psoriasis and often considered first-line systemic therapy due to their efficacy in this specific location, according to the American Academy of Dermatology 1, 2
Methotrexate is effective in a significant proportion of patients with palmoplantar psoriasis and is FDA-approved for severe, recalcitrant, disabling psoriasis, as recommended by the American Academy of Dermatology 1
Cyclosporine is effective for palmoplantar psoriasis but should be used with caution due to potential nephrotoxicity, as reported by the American Academy of Dermatology 1, 2

Palmar psoriasis significantly impacts quality of life, justifying the use of systemic therapies, according to the American Academy of Dermatology 1, 2
Caution is needed when using acitretin in women of childbearing potential due to its teratogenic effects and 3-year post-dosing pregnancy restriction, as reported by the American Academy of Dermatology 7
Combination therapy with acitretin and PUVA can enhance efficacy and reduce the number of PUVA treatments needed, potentially decreasing the risk of PUVA-associated skin malignancies, according to the British Journal of Dermatology 6